Precipio EPS - Earnings per Share 2010-2025 | PRPO
Precipio eps - earnings per share from 2010 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Precipio Annual EPS |
| 2024 |
$-2.93 |
| 2023 |
$-4.51 |
| 2022 |
$-10.73 |
| 2021 |
$-8.00 |
| 2020 |
$-17.00 |
| 2019 |
$-46.60 |
| 2018 |
$-276.40 |
| 2017 |
$-2,146.93 |
| 2016 |
$-2,830.59 |
| 2015 |
$-25,032.53 |
| 2014 |
$-18,099.06 |
| 2013 |
$-20,710.37 |
| 2012 |
$-13,956.99 |
| 2011 |
$-23,591.81 |
| 2010 |
$-0.06 |
| 2009 |
$-0.04 |
| Precipio Quarterly EPS |
| 2025-03-31 |
$-0.59 |
| 2024-12-31 |
$-0.22 |
| 2024-09-30 |
$-0.42 |
| 2024-06-30 |
$-0.83 |
| 2024-03-31 |
$-1.46 |
| 2023-12-31 |
$1.02 |
| 2023-09-30 |
$-1.04 |
| 2023-06-30 |
$-1.88 |
| 2023-03-31 |
$-2.61 |
| 2022-12-31 |
$-2.14 |
| 2022-09-30 |
$-2.79 |
| 2022-06-30 |
$-1.80 |
| 2022-03-31 |
$-4.00 |
| 2021-12-31 |
$-2.00 |
| 2021-09-30 |
$-1.60 |
| 2021-06-30 |
$-2.80 |
| 2021-03-31 |
$-1.60 |
| 2020-12-31 |
$6.80 |
| 2020-09-30 |
$-4.20 |
| 2020-06-30 |
$-4.00 |
| 2020-03-31 |
$-15.60 |
| 2019-12-31 |
$-9.80 |
| 2019-09-30 |
$-6.20 |
| 2019-06-30 |
$-21.00 |
| 2019-03-31 |
$-9.60 |
| 2018-12-31 |
$-38.80 |
| 2018-09-30 |
$-49.80 |
| 2018-06-30 |
$-45.80 |
| 2018-03-31 |
$-142.00 |
| 2017-12-31 |
$3,370.32 |
| 2017-09-30 |
$-407.80 |
| 2017-06-30 |
$-4,602.70 |
| 2017-03-31 |
$-506.75 |
| 2016-12-31 |
$-556.10 |
| 2016-09-30 |
$-344.83 |
| 2016-06-30 |
$-308.85 |
| 2016-03-31 |
$-1,620.81 |
| 2015-12-31 |
$-14,137.08 |
| 2015-09-30 |
$-4,952.48 |
| 2015-06-30 |
$-2,701.35 |
| 2015-03-31 |
$-3,241.62 |
| 2014-12-31 |
$-7,113.56 |
| 2014-09-30 |
$-450.23 |
| 2014-06-30 |
$-5,132.57 |
| 2014-03-31 |
$-5,402.71 |
| 2013-12-31 |
$-5,132.57 |
| 2013-09-30 |
$-7,023.52 |
| 2013-06-30 |
$-3,691.85 |
| 2013-03-31 |
$-4,862.43 |
| 2012-12-31 |
$-13,956.89 |
| 2012-09-30 |
$-0.04 |
| 2012-06-30 |
$-0.01 |
| 2012-03-31 |
$-0.05 |
| 2011-12-31 |
$-23,591.59 |
| 2011-09-30 |
$-0.03 |
| 2011-06-30 |
$-0.13 |
| 2011-03-31 |
$-0.06 |
| 2010-12-31 |
$-0.01 |
| 2010-09-30 |
$-0.02 |
| 2010-06-30 |
$-0.02 |
| 2010-03-31 |
$-0.01 |
| 2009-12-31 |
$0.00 |
| 2009-09-30 |
$-0.01 |
| 2009-06-30 |
$-0.01 |
| 2009-03-31 |
$-0.02 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.012B |
$0.019B |
|
Precipio Inc. has built a platform designed to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class academic institutions specializing in cancer research, diagnostics and treatment, Precipio offers a new standard of diagnostic accuracy enabling the highest level of patient care. Precipio Inc., formerly known as Transgenomic Inc., is based in Omaha, United States of America.
|
